护理学报 ›› 2022, Vol. 29 ›› Issue (3): 46-51.doi: 10.16460/j.issn1008-9969.2022.03.046
向御婷, 褚婕, 严敏, 乐曲, 余嘉欣
XIANG Yu-ting, CHU Jie, YAN Min, LE Qu, YU Jia-xin
摘要: 目的 获取国内外孕产妇孕产期相关静脉血栓风险评估的最佳证据,为构建评估工具提供参考依据。方法 应用循证医学的方法,通过计算机检索Up To Data、BMJ、Cochrane Library、JBI、GIN、NCG、NICE、CMA、RNAO、PubMed、Embase、中国知网、万方数据库、中国生物医学数据库,选取符合纳入标准的相关文献,并通过2名研究员对文献进行独立的质量评价、证据提取及总结。结果 共纳入文献12篇,其中包括临床实践指南6篇,高级临床决策1篇,系统评价5篇。从12篇文献中提取26条证据,最终整合形成4个维度,分别为既往因素(9条)、妊娠因素(4条)、产后因素(7条)和临时因素(6条)。结论 基于循证证据总结孕产妇孕产期静脉血栓栓塞风险最佳证据,实现对孕产妇孕产期静脉血栓栓塞发生风险的动态评估,通过风险分层达到个体化风险管理的目的。
中图分类号:
[1] 马信龙,张建敏,马剑雄,等.骨科大手术后静脉血栓栓塞症的研究进展[J]. 中华骨科杂志, 2016, 36(15):995-1001. DOI:10.3760/cma.j.issn.0253-2352.2016.15.007. [2] Malhotra A, Weinberger SE.Deep Vein Thrombosis in Pregnancy: Epidemiology, Pathogenesis,Diagnosis[EB/OL].(2019-09-19)[2020-06-16]. https://www.uptodate.com/contents/zh-Hans/pulmonary-embolism-in-pregnancy-epidemiology-pathogenesis-and-diagnosis?search=Deep%20vein%20thrombosis%20in%20pregnancy:%20Epidemiology,%20pathogenesis,%20and%20diagnosis&topicRef=1349&source=see_link. [3] Kujovich JL.Hormones and Pregnancy:Thromboembolic Risks for Women[J]. Br J Haematol, 2015, 126(4):443-454. DOI:10.1111/j.1365-2141.2004.05041.x. [4] Chang J, Elam-Evans LD, Berg CJ, et al.Pregnancy-related Mortality Surveillance—United States,1991—1999[J]. MMWR Surveill Summ, 2003, 52(2):1-8. DOI:Pregnancy-relatedMortalitySurveillance—UnitedStates,1991—1999[J].MMWRSurveillSumm,2003,52(2):1-8.DOI:http://dx.doi.org/. [5] Bourjeily G, Paidas M, Khalil H, et al.Pulmonary Embolism in Pregnancy[J]. Lancet, 2010, 375(9713):500-512. DOI:10.1016/s0140-6736(09)60996-x. [6] Okoroh EM, Azonobi IC, Grosse SD, et al.Prevention of Venous Thromboembolism in Pregnancy: A Review of Guidelines, 2000-2011[J]. J Womens Health, 2012, 21(6):611-615. DOI:10.1089/jwh.2012.3600. [7] Royal College of Obstetricians and Gynaecologists. Reducing the Risk of Venous Thromboembolism during Pregnancy and the Puerperium(Green-top Guideline No 37a)[EB/OL]. (2015-04-13)[2021-02-15].https://www.rcog.org.uk/en/guidelines-research-services/guidelines/gtg37a/. [8] Linnemann B, Bauersachs R, Rott H, et al.Diagnosis of Pregnancy-associated Venous Thromboembolism-position Paper of the Working Group in Women's Health of the Society of Thrombosis and Haemostasis (GTH)[J]. Vasa, 2016, 45(2):87-101. DOI:10.1024/0301-1526/a000503. [9] Bates SM, Middeldorp S, Rodger M, et al.Guidance for the Treatment and Prevention of Obstetric-associated Venous Thromboembolism[J]. J Thromb Thrombolysis, 2016, 41(1):92-128. DOI:10.1007/s11239-015-1309-0. [10] James AH.Thrombosis in Pregnancy and Maternal Outcomes[J]. Birth Defects Res C Embryo Today, 2015,105(3):159-166. DOI:10.1002/bdrc.21106. [11] Kearon C, Akl EA, Comerota AJ, et al.Antithrombotic Therapy for VTE Disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-based Clinical Practice Guidelines[J]. Chest, 2012, 141(2):e419S-e496S. DOI:10.1378/chest.11-2301. [12] 左红霞,牛玉明,程艳丽.循证护理证据资源的检索[J].循证护理,2015,1(4):145-151.DOI:10.3969/j.issn.2095-8668.2015.04.001. [13] 谢利民,王文岳.《临床指南研究与评价系统Ⅱ》简介[J].中西医结合学报,2012,10(2):160-165.DOI:10.3736/jcim20120206. [14] 朱丽群,庄若,曹松梅,等. PICC相关性血栓风险评估的最佳证据总结[J].中华护理杂志, 2017, 52(10):1179-1185. DOI:10.3761/j.issn.0254-1769.2017.10.005. [15] 王春青,胡雁. JBI证据预分级及证据推荐级别系统(2014版)[J]. 护士进修杂志, 2015, 30(11):964-967. DOI:10.16821/j.cnki.hsjx.2015.11.002. [16] 王亚玲,王冰寒,张艳,等. 急性缺血性脑卒中患者溶栓术后预防出血转化的最佳证据总结[J].护理学报, 2021, 28(3):46-52. DOI:10.16460/j.issn1008-9969.2021.03.046. [17] 严玉娇,丁娟,刘晁含,等.成人危重症患者气道管理的最佳证据总结[J].护理学报, 2021, 28(3):39-45.DOI:10.16460/j.issn1008-9969.2021.03.039. [18] Bates SM, Greer IA, Middeldorp S, et al.VTE, Thrombophilia, Antithrombotic Therapy, and Pregnancy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-based Clinical Practice Guidelines[J]. Chest,2012:e691S-e736S. [19] Kearon C, Akl EA, Ornelas J, et al.Antithrombotic Therapy for VTE Disease: CHEST Guideline and Expert Panel Report[J].Chest,2016,149(2):315-352.DOI:10.1016/j.chest.2015.11.026. [20] Bates SM, Rajasekhar A, Middeldorp S, et al.American Society of Hematology 2018 Guidelines for Management of Venous Thromboembolism: Venous Thromboembolism in the Context of Pregnancy[J]. Blood Adv, 2018, 2(22): 3317-3359. DOI:10.1182/bloodadvances.2018024802. [21] Chan WS, Rey E, Kent NE, et al.Venous Thromboembolism and Antithrombotic Therapy in Pregnancy[J].J Obstet Gynaecol Can, 2014, 36(6):527-553. DOI:10.1016/s1701-2163(15)30569-7. [22] Romero A, Alonso C, Rincon M, et al.Risk of Venous Thromboembolic Disease in Women a Qualitative Systematic Review[J]. Eur J Obstet Gynecol Reprod Biol, 2005, 121(1):8-17. DOI:10.1016/j.ejogrb.2004.11.023. [23] Croles FN, Nasserinejad K, Duvekot JJ, et al.Pregnancy, Thrombophilia, and the Risk of a First Venous Thrombosis: Systematic Review and Bayesian Meta-analysis[J]. BMJ, 2017, 359:j4452. DOI:10.1136/bmj.j4452. [24] Biron-Andreani C, Schved JF, Daures JP.Factor V Leiden Mutation and Pregnancy-related Venous Thromboembolism: What Is the Exact Risk? Results from a Meta-analysis[J]. Thromb Haemost, 2006, 96(1):14-18. DOI:10.1160/TH06-02-0086. [25] Kim YH, Pfaller B, Marson A, et al.The Risk of Venous Thromboembolism in Women with Inflammatory Bowel Disease During Pregnancy and the Postpartum Period: A Systematic Review and Meta-analysis[J]. Medicine (Baltimore),2019,98(38):e17309.DOI:10.1097/MD.0000000000017309. [26] Kemmeren JM, Algra A, Grobbee DE.Third Generation Oral Contraceptives and Risk of Venous Thrombosis: Meta-analysis[J]. BMJ, 2001, 323(7305):131-134. DOI:10.1136/bmj.323.7305.131. [27] Robertson L, Wu O, Langhorne P, et al.Thrombophilia in Pregnancy:A Systematic Review[J]. Br J Haematol, 2006, 132(2):171-196. DOI:10.1111/j.1365-2141.2005.05847.x. [28] He R, O'connell Cm, Ks J, et al.Maternal Outcomes in Pregnancies Complicated by Obesity[J]. Obstet Gynecol, 2005,106(6):1357-1364.DOI:10.1097/01.AOG.0000188387.88032.41. [29] Larsen TB, Sørensen HT, Gislum M, et al.Maternal Smoking, Obesity, and Risk of Venous Thromboembolism During Pregnancy and the Puerperium: A Population-based Nested Case-control Study[J]. Thromb Res, 2007, 120(4):505-509. DOI:10.1016/j.thromres.2006.12.003. [30] Pabinger I, Grafenhofer H, Pa K, et al.Temporary Increase in the Risk for Recurrence During Pregnancy in Women with a History of Venous Thromboembolism[J].Blood, 2002, 100(3):1060-1062. DOI:10.1182/blood-2002-01-0149. [31] 李东繁,杜旭升,刘安. Padua风险评估模型在慢性阻塞性肺疾病急性加重期患者并发静脉血栓栓塞疾病预防中的作用[J]. 陕西医学杂志, 2016, 45(11):1509-1510. DOI:10.3969/j.issn.1000-7377.2016.11.028. [32] 陶俊荣,宋红霞. Padua风险评估模型在预防内科住院患者静脉血栓栓塞症中的应用[J].中国实用护理杂志, 2018, 34(32):2496-2501.DOI:10.3760/cma.j.issn.1672-7088.2018.32.004. [33] Pannucci CJ,Swistun L, Macdonald JK, et al.Individualized Venous Thromboembolism Risk Stratification Using the 2005 Caprini Score to Identify the Benefits and Harms of Chemoprophylaxis in Surgical Patients: A Meta-analysis[J]. Ann Surg, 2017, 265(6):1094-1103. DOI:10.1097/SLA.0000000000002126. [34] 徐留海,曾勇,黄卫,等.基于Caprini血栓风险模型评估膝关节镜手术患者深静脉血栓形成的风险性[J]. 中国组织工程研究, 2016, 20(17):24434-24440. DOI:10.3969/j.issn.2095-4344.2016.17.006. [35] Knight M.Antenatal Pulmonary Embolism: Risk Factors, Management and Outcomes[J]. BJOG, 2008, 115(4):453-461. DOI:10.1111/j.1471-0528.2007.01622.x. [36] Steegers EA, Von Dadelszen P, Duvekot JJ, et al.Pre-eclampsia[J]. Lancet, 2010, 376(9741):631-644. DOI:10.1016/s0140-6736(10)60279-6. [37] Sheppard BL, Bonnar J.An Ultrastructural Study of Utero-placental Spiral Arteries in Hypertensive and Normotensive Pregnancy and Fetal Growth Retardation[J]. Br J Obstet Gynaecol, 1981, 88(7):695-705. DOI:10.1111/j.1471-0528.1981.tb01268.x. [38] Lindqvist P, Dahlbäck B, Marŝál K. Thrombotic Risk During Pregnancy: A Population Study[J]. Obstet Gynecol, 1999, 94(4):595-599. 10.1016/s0029-7844(99)00308-7. [39] Jacobsen AF,Skjeldestad FE, Sandset PM.Ante- and Postnatal Risk Factors of Venous Thrombosis:A Hospital-based Case-control Study[J]. J Thromb Haemost, 2008, 6(6): 905-912. DOI:10.1111/j.1538-7836.2008.02961.x. [40] Sultan AA, Tata LJ, West J, et al.Risk Factors for First Venous Thromboembolism Around Pregnancy: A Population-based Cohort Study from the United Kingdom[J]. Blood, 2013,121(19):3953-3961.DOI:10.1182/blood-2012-11-469551. [41] Liu S, Liston RM, Joseph KS, et al.Maternal Health Study Group of the Canadian Perinatal Surveillance System. Maternal Mortality and Severe Morbidity Associated with Low-risk Planned Cesarean Delivery Versus Planned Vaginal Delivery at Term[J]. Obstetrical & Gynecological Survey, 2007,62(8):499-500.DOI:10.1097/01.ogx.0000271111.20802.e0. [42] Caprini JA,Arcelus JI, Hasty JH, et al.Clinical Assessment of Venous Thromboembolic Risk in Surgical Patients[J]. Semin Thromb Hemost, 1991,17(Suppl 3):304-312.DOI:10.1055/s-2007-1002590. |
[1] | 赵晓蕊, 龙云, 陈思齐, 白洁, 肖霄, 朱社宁. 妇科恶性肿瘤患者术后胃肠功能紊乱风险预测模型的构建及验证[J]. 护理学报, 2022, 29(3): 72-78. |
[2] | 龚艳, 蒋琪霞, 陈文芳, 王海宏, 马丽. 手术获得性压力性损伤风险评估量表对手术患者压力性损伤预测效果的研究[J]. 护理学报, 2021, 28(9): 66-70. |
[3] | 严露培, 姚丽丽, 李跃荣, 陈豪, 刘文文, 赵庆华, 肖明朝. 手术患者非计划性术中低体温风险预测模型研究进展[J]. 护理学报, 2021, 28(6): 13-16. |
[4] | 蓝爱春, 包锦莹, 郑永克, 魏素妮, 潘静. 960名中老年人的颈围、小腿围对其血压、血脂、血糖的影响[J]. 护理学报, 2021, 28(3): 53-57. |
[5] | 张锐, 叶向红, 赵泽华, 韩珍, 谢文慧, 吴翠丽. 腹部创伤患者肠内营养喂养不耐受预警评估指标体系的构建[J]. 护理学报, 2021, 28(23): 1-5. |
[6] | 李雪嘉, 杨开庆. 2型糖尿病患者酮症酸中毒风险预测模型的构建与验证[J]. 护理学报, 2021, 28(22): 12-17. |
[7] | 张萍, 刘丽萍. 气管插管患者非计划拔管风险评估量表的构建[J]. 护理学报, 2021, 28(21): 18-22. |
[8] | 陈敏, 郑伟琴, 陈华, 蔡文智, 陈玲, 苏丹, 万星阳. 2型糖尿病患者便秘风险列线图预测模型的建立与验证[J]. 护理学报, 2021, 28(2): 58-61. |
[9] | 胡惠菊, 韩静, 唐启群, 成杰, 李慧源. Morse跌倒评估量表与STEADI跌倒风险自评量表在养老机构老年人中的应用比较[J]. 护理学报, 2021, 28(19): 8-12. |
[10] | 陈莉, 沙菲, 李婷. 急性呼吸窘迫综合征风险预测模型的研究进展[J]. 护理学报, 2021, 28(15): 30-34. |
[11] | 姚勋霞, 张理想, 曹教育, 欧安平, 胡芳, 吴金玉. 外周静脉应用血管活性药物致静脉炎危险因素的评估指标体系构建[J]. 护理学报, 2021, 28(12): 65-70. |
[12] | 牛晓丹, 张静, 郭静波, 阮海慧, 迟俊婷, 陶红霞, 王艳红. 糖尿病患者衰弱危险因素的Meta分析[J]. 护理学报, 2021, 28(11): 1-6. |
[13] | 张煜, 张春艳, 金玉, 王淑芹, 董亮, 万娜, 贾燕瑞, 高凤莉. 内科危重症患者深静脉血栓预防审查指标的制定及障碍因素分析[J]. 护理学报, 2020, 27(4): 37-41. |
[14] | 王焕焕, 程湘玮, 王培红, 丁颖, 周英凤, 张纹, 熊彩霞, 吕永利, 屠凤鸣. 妊娠期糖尿病产妇分娩新生儿低血糖管理的最佳证据总结[J]. 护理学报, 2020, 27(3): 31-36. |
[15] | 陈琳, 葛铮铮, 张晓艳. 急性白血病患儿住院期间感染性腹泻影响因素病例对照研究[J]. 护理学报, 2020, 27(23): 53-57. |
|